This inventor holds 8 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: New York Stem Cell Foundation, Inc., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014-2024
Title: Dietrich M. Egli: A Pioneer in Stem Cell Research
Introduction
Dietrich M. Egli is a distinguished inventor based in New York, NY, recognized for his significant contributions to the field of stem cell research. With a remarkable portfolio of 8 patents, he has played a pivotal role in advancing our understanding of human embryonic stem cells and their applications in regenerative medicine.
Latest Patents
Egli's latest innovations revolve around the creation of haploid human embryonic stem cell lines and somatic cell lines. His patents detail the processes to produce these haploid human cells, including haploid multipotent human cells and haploid differentiated human cells. The methods outlined in his patents not only effectively describe the generation of these unique cell lines but also provide insights into their potential usage in scientific research and therapeutic applications.
Career Highlights
Throughout his career, Dietrich M. Egli has worked with influential organizations, including the New York Stem Cell Foundation and Yissum Research Development Company of the Hebrew University of Jerusalem. His expertise and innovative spirit have propelled advancements in stem cell technology, contributing to the foundation of essential methodologies in the field.
Collaborations
Egli has collaborated with notable scientists such as Nissim Benvenisty and Ido Sagi. These partnerships have strengthened his research endeavors, leading to significant breakthroughs in the understanding of stem cells and their applications in medical treatments.
Conclusion
Dietrich M. Egli stands out as a pivotal figure in stem cell research, with a robust portfolio of patents that reflect his innovative contributions. His work continues to have far-reaching impacts on the field, paving the way for future advancements in regenerative medicine. With ongoing collaborations and a commitment to research, Egli's influence is set to grow, inspiring the next generation of scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile